Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Souery

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 11, 2011
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPRJana Strohmaier, Stefan Wüst, Rudolf Uher, et al.
Neuroscience Letters|May 24, 2011
COMT and age at onset in mood disorders: a replication and extension studyIsabelle Massat, Neslihan Aygun Kocabas, Concetta Crisafulli, et al.
Neuropsychobiology|January 7, 2012
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depressionAlessandro Serretti, Alberto Chiesa, Concetta Crisafulli, et al.
Scientific Reports|April 5, 2018
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variablesRaquel Iniesta, Karen Hodgson, Daniel Stahl, et al.
The International Journal of Neuropsychopharmacology|November 10, 2024
Anhedonia is associated with a specific depression profile and poor antidepressant responseAntonina Luca, Maria Luca, Siegfried Kasper, et al.
Psychiatry Research|June 30, 2007
Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorderFilip Van Den Eede, Tine Venken, Jurgen Del-Favero, et al.
Neuroscience Letters|April 11, 2012
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depressionJulien Mendlewicz, Concetta Crisafulli, Raffaella Calati, et al.
Psychopharmacology|March 13, 2015
Exploring the role of drug-metabolising enzymes in antidepressant side effectsKaren Hodgson, Katherine E Tansey, Rudolf Uher, et al.
Journal of Psychopharmacology (Oxford, England)|January 14, 2014
Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) studyKaren Hodgson, Rudolf Uher, Andrew A Crawford, et al.
Translational Psychiatry|August 15, 2018
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)Hongyan Ren, Chiara Fabbri, Rudolf Uher, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 11, 2011
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPRJana Strohmaier, Stefan Wüst, Rudolf Uher, et al.
Neuroscience Letters|May 24, 2011
COMT and age at onset in mood disorders: a replication and extension studyIsabelle Massat, Neslihan Aygun Kocabas, Concetta Crisafulli, et al.
Neuropsychobiology|January 7, 2012
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depressionAlessandro Serretti, Alberto Chiesa, Concetta Crisafulli, et al.
Scientific Reports|April 5, 2018
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variablesRaquel Iniesta, Karen Hodgson, Daniel Stahl, et al.
The International Journal of Neuropsychopharmacology|November 10, 2024
Anhedonia is associated with a specific depression profile and poor antidepressant responseAntonina Luca, Maria Luca, Siegfried Kasper, et al.
Psychiatry Research|June 30, 2007
Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorderFilip Van Den Eede, Tine Venken, Jurgen Del-Favero, et al.
Neuroscience Letters|April 11, 2012
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depressionJulien Mendlewicz, Concetta Crisafulli, Raffaella Calati, et al.
Psychopharmacology|March 13, 2015
Exploring the role of drug-metabolising enzymes in antidepressant side effectsKaren Hodgson, Katherine E Tansey, Rudolf Uher, et al.
Journal of Psychopharmacology (Oxford, England)|January 14, 2014
Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) studyKaren Hodgson, Rudolf Uher, Andrew A Crawford, et al.
Translational Psychiatry|August 15, 2018
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)Hongyan Ren, Chiara Fabbri, Rudolf Uher, et al.
Pageof 17